Epilepsy: The Next Generation Drugs (A Review)

Amit Kumar Shrivastava; Manish Dhar Dwivedi

Authors

Amit Kumar Shrivastava
Manish Dhar Dwivedi

Keywords:

Abstract

Seizures are common and are treated in all branches of medicine. Approximately 10% of the population will have one or more seizures during their lifetime. Seizures are symptoms that occur in acute illness, ie, provoked seizures, or in epilepsy, ie, unprovoked seizures. Antiepileptic drugs (AEDs) are pharmacologic agents used to reduce the frequency of epileptic seizures. "Antiepileptic" drug is a misnomer, because these drugs are effective as symptomatic treatment of seizures, i.e., the symptoms of epilepsy, not as treatment of epilepsy itself. Recent discoveries in molecular biology and genetics have elucidated a genetic basis for some epilepsy syndromes, which will lead to new treatments. This review include new AEDs viz; Ganaxolone, Eslicarbazepine acetate, Fluorofel-bamate, Huperzine A, Carisbamate (RWJ-333369), Brivaracetam (ucb 34714), 2-Deoxy-D-glucose, Retigabine, T2000 , T2007, Valrocemide, Tonabersat (SB-220453), YKP3089, Propyl isopropyl acetamide, JZP-4, ICA-105665, NAX-5055, Perampanel and Valpromide.

Downloads

How to Cite

Epilepsy: The Next Generation Drugs (A Review). (2014). Global Journal of Medical Research, 14(B4), 19-27. https://medicalresearchjournal.org/index.php/GJMR/article/view/577

Download Citation

References

W Hauser, J Annegers, W Rocca (1996) Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. 71, 576-586.

Armin Haerer, Dallas Anderson, Bruce Schoenberg (1986) Prevalence and Clinical Features of Epilepsy in a Biracial United States Population. 27(1), 66-75.

W Hauser, J Annegers, W Rocca (1996) Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. 71, 578-586.

W Hauser, John Annegers, Leonard Kurland (1991) Prevalence of Epilepsy in Rochester, Minnesota: 1940-1980. 32(4), 429-445.

W Hauser, J Annegers, L Kurland (1993) Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. 34, 453-468.

J Annegers, W Rocca, W Hauser (1996) Causes of epilepsy: contributions of the Rochester epidemiology project. 71, 570-575.

Virinder Nohria, Earl Giller (2004) Ganaxolone. 4(1), 102-105.

Richard Carter, Paul Wood, Scott Wieland, Jon Hawkinson, Delia Belelli, Jeremy Lambert, H White, Harold Wolf, Seid Mirsadeghi, S Tahir, Michael Bolger, Nancy Lan, Kelvin Gee (1997) Characterization of the Anticonvulsant Properties of Ganaxolone (CCD 1042; 3α-Hydroxy-3β-methyl-5α-pregnan-20-one), a Selective, High-Affinity, Steroid Modulator of the γ-Aminobutyric AcidA Receptor. 280(3), 1284-1295.

M Le´skiewicz, B Budziszewska, L Jaworska-Feil, M Kubera, W Basta-Kaim Lason (2003) Inhibitory effect of some neuroactive steroids on cocaine-induced kindling in mice. 55, 1131-1136.

M Rogawski, D Reddy (2004) Neurosteroids: endogenous modulators of seizure susceptibility. 319-355.

G Biagini, E Baldelli, D Longo, L Pradelli, I Zini, M Rogawski, M Avoli (2006) Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. 201, 519-524.

Jan Benes, António Parada, Anabela Figueiredo, Paula Alves, Ana Freitas, David Learmonth, Rodrigo Cunha, José Garrett, Patrício Soares-Da-Silva (1999) Anticonvulsant and Sodium Channel-Blocking Properties of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide Derivatives. 42(14), 2582-2587.

Ambrosio, Silva Araujo, I, Malva Soaresda-Silva, P Carvalho, A Carvalho, C (2000) Neurotoxic/ neuroprotective profile of carbamazepine, oxcarba-zepine and two new putative antiepileptic drugs, BIA 2-093 and BIA 2-024. 406, 191-201.

Rodrigo Cunha, Joana Coelho, Ana Costenla, Luísa Lopes, António Parada, Alexandre De Mendonça, Ana Sebastião, J Ribeiro (2002) Effects of Carbamazepine and Novel 10,11‐Dihydro‐5H‐Dibenz[b,f]Azepine‐5‐Carboxamide Derivatives on Synaptic Transmission in Rat Hippocampal Slices. 90(4), 208-213.

Luis Almeida, Patrício Soares-Da-Silva (2007) Eslicarbazepine Acetate (BIA 2-093). 4(1), 88-96.

Jarrod Ward, Vittorio Caprio (2006) A radical mediated approach to the core structure of huperzine A. 47(4), 553-556.

M Bialer, S Johannessen, H Kupferberg, Levy Perucca, E Tomson, T (2004) Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). 61, 1-48.

Wallis Panizzon, K Niquet, J Masaratis, L Baldwin, R Wasterlain, C (2000) Neuroprotective effects of the anticonvulsant, fluorofelbamate. 41(7), 162.

H White, S Schachter, D Lee, J Xiaoshen, D Eisenberg (2005) Anticonvulsant activity of Huperzine A, an alkaloid extract of Chinese club moss (Huperzia serrata). 46(8), 220.

Andrea Zangara (2003) The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. 75(3), 675-686.

H White, A Srivastava, B Klein (2006) The novel investigational neuromodulator RWJ-333369 displays a broad-spectrum anticonvulsant profile in rodent seizure and epilepsy models. 27.

Heidi Grabenstatter, F Dudek (2008) A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate‐induced epilepsy. 49(10), 1787-1794.

Isabelle Niespodziany, Jean‐michel Rigo, Gustave Moonen, Alain Matagne, Henrik Klitgaard, Christian Wolff (2009) Brivaracetam does not modulate ionotropic channels activated by glutamate, γ‐aminobutyric acid, and glycine in hippocampal neurons. 58(11), 107.

R Kaminski, A Matagne, K Leclercq, M Gillard, P Michel, B Kenda, P Talaga, H Klitgaard (2008) SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. 54, 715-720.

A Matagne, D‐g Margineanu, B Kenda, P Michel, H Klitgaard (2008) Anti‐convulsive and anti‐epileptic properties of brivaracetam (ucb 34714), a high‐affinity ligand for the synaptic vesicle protein, SV2A. 154(8), 1662-1671.

J Berwick, D Johnston, M Jones, J Martindale, C Martin, A Kennerley, P Redgrave, J Mayhew (2008) Fine Detail of Neurovascular Coupling Revealed by Spatiotemporal Analysis of the Hemodynamic Response to Single Whisker Stimulation in Rat Barrel Cortex. 99(2), 787-798.

Chris Rundfeldt, Rainer Netzer (2000) The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits. 282(1-2), 73-76.

Ofer Spiegelstein, Boris Yagen, Meir Bialer (1999) Structure‐Pharmacokinetic‐Pharmacodynamic Relationships of yV‐Alkyl Derivatives of the New Antiepileptic Drug Valproyl Glycinamide. 40(5), 545-552.

M Bialer, S Johannessen, H Kupferberg, R Levy, P Loiseau, E Perucca (2001) Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V). 43(1), 11-58.

M Bialer, S Johannessen, H Kupferberg, Levy Loiseau, P Perucca, E (2002) Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). 51, 31-71.

Andrew Parsons, Sharon Bingham, Pravin Raval, Simon Read, Mervyn Thompson, Neil Upton (2001) Tonabersat (SB‐220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve‐induced neurovascular reflexes. 132(7), 1549-1557.

Meir Bialer, Svein Johannessen, René Levy, Emilio Perucca, Torbjörn Tomson, H White (2010) Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X). 92(2-3), 89-124.

M Bialer (1991) Clinical pharmacology of valpromide. 20, 114-122.

Meir Bialer, Svein Johannessen, Harvey Kupferberg, René Levy, Emilio Perucca, Torbjörn Tomson (2007) Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII). 73(1), 1-52.

A Funk, R Ricci, Anderson, Arana De Colle, C, Wang, George Single doses of JZP-4 decrease cortical excitability. A transcranial magnetic stimulation study.

Binnie, Kasteleijn-Nolst Trenité, D, De Korte, R (1986) Photosensitivity as a model for acute antiepileptic drug studies. 63, 35-41.

H White, Erika Scholl, Brian Klein, Sean Flynn, Timothy Pruess, Brad Green, Liuyin Zhang, Grzegorz Bulaj (2009) Developing Novel Antiepileptic Drugs: Characterization of NAX 5055, a Systemically-Active Galanin Analog, in Epilepsy Models. 6(2), 372-380.

Y Hashizume, T Hanada, A Ogasawara, M Ueno, Y Nishizawa (2008) Anticonvulsant activity of perampanel, a selective AMPA receptor antagonist, in rodent models of epileptic seizure. 02.

G Shaltiel, M Shirley, Ora Belmaker, R Agam, G (2007) Effect of valproate derivatives on human brain myo-inositol-1-phosphate (MIP) synthase activity and amphetamine-induced rearing. 59, 402-407.